Posted in | News | Laser

LightMachinery Awarded Patent for the Universal Beam Splitter

Editorial Checklist Reviewed

The surprise and confusion caused by the simplicity and novelty of the universal beam splitter is well known to the staff at LightMachinery based on our interaction with customers on the phone and at trade shows.

A simple thin etalon with a relatively low finesse has a reflection and transmission for any given wavelength that is very angle dependent. Change the angle and change the R/T ratio from 1/99 to 90/10 or anywhere in between. This novelty has now also been recognized by the US Patent Office.

Source:

http://www.lightmachinery.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    LightMachinery. (2019, August 20). LightMachinery Awarded Patent for the Universal Beam Splitter. AZoOptics. Retrieved on November 21, 2024 from https://www.azooptics.com/News.aspx?newsID=24502.

  • MLA

    LightMachinery. "LightMachinery Awarded Patent for the Universal Beam Splitter". AZoOptics. 21 November 2024. <https://www.azooptics.com/News.aspx?newsID=24502>.

  • Chicago

    LightMachinery. "LightMachinery Awarded Patent for the Universal Beam Splitter". AZoOptics. https://www.azooptics.com/News.aspx?newsID=24502. (accessed November 21, 2024).

  • Harvard

    LightMachinery. 2019. LightMachinery Awarded Patent for the Universal Beam Splitter. AZoOptics, viewed 21 November 2024, https://www.azooptics.com/News.aspx?newsID=24502.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Trending News Stories

More Content from LightMachinery

See all content from LightMachinery

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback